Requirement for capital would be the main reason. As always it’s just our capital position that holds us back. Once sorted again we will re rate with FDA trials early next year.
- Forums
- ASX - By Stock
- CEO interview on Proactive Investors
Requirement for capital would be the main reason. As always it’s...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 191 | $17.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.55 | 2592 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 191 | 17.150 |
1 | 178 | 17.050 |
1 | 196 | 16.950 |
1 | 42 | 16.900 |
1 | 1000 | 16.850 |
Price($) | Vol. | No. |
---|---|---|
16.550 | 2592 | 2 |
16.850 | 5 | 1 |
17.500 | 500 | 1 |
17.800 | 200 | 1 |
18.240 | 500 | 1 |
Last trade - 16.14pm 23/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online